Computerized surveillance of adverse drug reactions in hospital: Implementation

被引:63
|
作者
Levy, M [1 ]
Azaz-Livshits, T
Sadan, B
Shalit, M
Geisslinger, G
Brune, K
机构
[1] Hadassah Univ Hosp, Dept Med, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany
关键词
hospital pharmacoepidemiology; hospital information systems; adverse drug reactions; hospital drug surveillance;
D O I
10.1007/s002280050571
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To implement and measure the effects of automatic computerized laboratory signals (ALS) as a detection support tool of adverse drug reactions (ADRs) in hospital. Methods: This was a prospective observational study of a total of 192 patients (199 sequential medical admissions) during a 2-month period in a 34-bed medical ward at the Hadassah University Hospital, Jerusalem, Israel. The study involved the routine (daily) distribution to staff physicians of lists of automatic signals generated from computerized laboratory data as potential indicators of ADRs. Patient charts were reviewed by the clinical pharmacology team for ADRs and to see whether these were recognized by the staff physicians. Results: Seventy-one ADRs were detected in 64 of the 199 (32%) admissions. Twenty-seven per cent of the ADRs were serious, 9% of the admissions were due to ADRs. Two hundred and ninety-five ALS were generated involving 69% of the admissions. Sixty-one per cent of the ADRs were identified by ALS. ALS were present in 58% of the ADR negative admissions. Eighty-five per cent of the ADRs were recognized as such and 19% of the ALS-positive ADRs were not recognized by the staff physicians. Conclusions: The routine implementation of ALS doubled the number of ADRs recognized by the physicians while patients were hospitalized in the medical ward. The use of the system appeared valid, simple and potentially cost-effective.
引用
收藏
页码:887 / 892
页数:6
相关论文
共 50 条
  • [21] POSTMARKETING SURVEILLANCE OF ADVERSE DRUG-REACTIONS
    CASTLE, WM
    LEWIS, JA
    BRITISH MEDICAL JOURNAL, 1984, 288 (6428): : 1458 - 1459
  • [22] HOSPITAL ADMISSIONS DUE TO ADVERSE DRUG REACTIONS - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM
    MILLER, RR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (01) : 142 - 143
  • [23] Design and Implementation of a Computerized Management System for Adverse Drug Reactions at the Souro SANOU University Hospital (CHUSS) in Bobo-Dioulasso, Burkina Faso
    Traore, Arsene Sie Hamed
    Barro, Seydou Golo
    Fofana, Souleymane
    Sombie, Issiaka
    Semde, Rasmané
    De Vriese, Carine
    Ilboudo, Dieudonne
    Staccini, Pascal
    Studies in Health Technology and Informatics, 2022, 289 : 144 - 147
  • [24] Comprehensive surveillance of adverse drug reactions in hospital provides important data to inform the safe use of drug therapy
    Mednick S.C.
    Nakayama K.
    Cantero J.L.
    Atienza M.
    Levin A.A.
    Pathak N.
    Stickgold R.
    Drugs & Therapy Perspectives, 2002, 18 (12) : 14 - 16
  • [25] High rates of adverse drug events in a highly computerized hospital
    Nebeker, JR
    Hoffman, JM
    Weir, CR
    Bennett, CL
    Hurdle, JF
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) : 1111 - 1116
  • [26] INTENSE SURVEILLANCE AND DETECTION OF ADVERSE DRUG REACTIONS BY PHYSICIANS
    ADAMS, LL
    FALLON, HJ
    GRAY, TK
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1972, 6 (01) : 97 - &
  • [27] Post-marketing surveillance and adverse drug reactions
    Shani, S
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 1999, 1 (02): : 117 - 119
  • [28] ASSESSMENT OF ADVERSE REACTIONS WITHIN A DRUG SURVEILLANCE PROGRAM
    BORDA, IT
    SLONE, D
    JICK, H
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 205 (09): : 645 - &
  • [29] Surveillance for fatal suspected adverse drug reactions in the UK
    Clarkson, A
    Choonara, I
    ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 87 (06) : 462 - 466
  • [30] ADVERSE DRUG REACTIONS IN A COMPLEMENTARY MEDICINE HOSPITAL
    Suesskind, M.
    Lueke, C.
    Jeschke, E.
    Pichl, S.
    Thuermann, P.
    Matthes, H.
    Ostermann, T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 57 - 57